Cite
Discovery of 5-(2′,4′-difluorophenyl)-salicylanilides as new inhibitors of receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis.
MLA
Lee, Chia-Chung, et al. “Discovery of 5-(2′,4′-Difluorophenyl)-Salicylanilides as New Inhibitors of Receptor Activator of NF-ΚB Ligand (RANKL)-Induced Osteoclastogenesis.” European Journal of Medicinal Chemistry, vol. 98, June 2015, pp. 115–26. EBSCOhost, https://doi.org/10.1016/j.ejmech.2015.05.015.
APA
Lee, C.-C., Liu, F.-L., Chen, C.-L., Chen, T.-C., Chang, D.-M., & Huang, H.-S. (2015). Discovery of 5-(2′,4′-difluorophenyl)-salicylanilides as new inhibitors of receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis. European Journal of Medicinal Chemistry, 98, 115–126. https://doi.org/10.1016/j.ejmech.2015.05.015
Chicago
Lee, Chia-Chung, Fei-Lan Liu, Chun-Liang Chen, Tsung-Chih Chen, Deh-Ming Chang, and Hsu-Shan Huang. 2015. “Discovery of 5-(2′,4′-Difluorophenyl)-Salicylanilides as New Inhibitors of Receptor Activator of NF-ΚB Ligand (RANKL)-Induced Osteoclastogenesis.” European Journal of Medicinal Chemistry 98 (June): 115–26. doi:10.1016/j.ejmech.2015.05.015.